Total Payments
$9,182
2024 Payments
$2,086
Companies
29
Transactions
465
Medicare Patients
1,570
Medicare Billing
$128,349
Payment Breakdown by Category
Food & Beverage$9,059 (98.7%)
Other$82.49 (0.9%)
Education$39.83 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,059 | 462 | 98.7% |
| Long term medical supply or device loan | $82.49 | 1 | 0.9% |
| Education | $39.83 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,109 | 123 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,522 | 86 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $860.09 | 36 | $0 (2024) |
| Gilead Sciences, Inc. | $719.78 | 40 | $0 (2024) |
| Janssen Biotech, Inc. | $496.15 | 23 | $0 (2024) |
| QOL Medical, LLC | $424.89 | 16 | $0 (2024) |
| Celgene Corporation | $368.95 | 21 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $310.16 | 15 | $0 (2024) |
| Ardelyx, Inc. | $300.27 | 14 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $293.82 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,086 | 110 | ABBVIE INC. ($397.51) |
| 2023 | $2,350 | 115 | ABBVIE INC. ($552.99) |
| 2022 | $2,697 | 134 | ABBVIE INC. ($663.74) |
| 2021 | $2,049 | 106 | AbbVie Inc. ($494.79) |
All Payment Transactions
465 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.10 | General |
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/26/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/25/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $29.40 | General |
| Category: LIVER DISEASE | ||||||
| 11/22/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $15.33 | General |
| Category: GI | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $28.54 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $30.74 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $10.16 | General |
| Category: Gastroenterology | ||||||
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/01/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.89 | General |
| 10/30/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $3.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $32.52 | General |
| Category: VIROLOGY | ||||||
| 10/21/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 10/17/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $18.95 | General |
| Category: GI | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.64 | General |
| Category: Neuroscience | ||||||
| 10/14/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $1.09 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 352 | 392 | $70,977 | $27,938 |
| 2022 | 6 | 400 | 440 | $81,076 | $32,091 |
| 2021 | 6 | 419 | 467 | $87,117 | $35,544 |
| 2020 | 6 | 399 | 462 | $85,460 | $32,776 |
Total Patients
1,570
Total Services
1,761
Medicare Billing
$128,349
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 110 | 114 | $15,048 | $6,413 | 42.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 52 | 55 | $13,750 | $5,069 | 36.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 58 | $11,484 | $4,812 | 41.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 53 | 83 | $11,205 | $4,648 | 41.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 52 | 52 | $10,400 | $3,644 | 35.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $9,090 | $3,352 | 36.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 116 | 129 | $17,028 | $7,446 | 43.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 74 | 74 | $18,500 | $7,170 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 58 | 61 | $12,078 | $5,331 | 44.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 66 | 90 | $12,150 | $4,601 | 37.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 40 | 40 | $12,120 | $4,239 | 35.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 46 | 46 | $9,200 | $3,304 | 35.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 89 | 92 | $23,000 | $9,032 | 39.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 91 | 97 | $19,206 | $8,567 | 44.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 105 | 110 | $14,520 | $6,462 | 44.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 74 | 108 | $14,580 | $5,551 | 38.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 37 | 37 | $11,211 | $4,106 | 36.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 23 | 23 | $4,600 | $1,827 | 39.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 102 | 118 | $23,364 | $8,730 | 37.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 120 | 129 | $17,028 | $6,692 | 39.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 60 | 61 | $15,250 | $6,212 | 40.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 46 | 46 | $13,938 | $4,956 | 35.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 51 | 88 | $11,880 | $4,700 | 39.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 20 | 20 | $4,000 | $1,487 | 37.2% |
About Richard Whitehead, PAC
Richard Whitehead, PAC is a Medical healthcare provider based in Middletown, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1487630919.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Richard Whitehead, PAC has received a total of $9,182 in payments from pharmaceutical and medical device companies, with $2,086 received in 2024. These payments were reported across 465 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($9,059).
As a Medicare-enrolled provider, Whitehead has provided services to 1,570 Medicare beneficiaries, totaling 1,761 services with total Medicare billing of $128,349. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Other Specialties Physician Assistant
- Location Middletown, CT
- Active Since 12/16/2005
- Last Updated 03/25/2015
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1487630919
Products in Payments
- XIFAXAN (Drug) $1,047
- ENTYVIO (Biological) $629.25
- ZEPOSIA (Drug) $507.68
- TRULANCE (Drug) $475.25
- SKYRIZI (Biological) $456.87
- STELARA (Biological) $357.31
- SUCRAID (Drug) $351.00
- RINVOQ (Biological) $346.04
- DUPIXENT (Biological) $345.97
- LINZESS (Drug) $324.19
- Linzess (Drug) $310.16
- IBSRELA (Drug) $300.27
- HUMIRA (Biological) $293.84
- OCALIVA (Drug) $255.77
- MAVYRET (Drug) $248.12
- VIBERZI (Drug) $224.35
- ZENPEP (Drug) $199.51
- CREON (Drug) $188.36
- XELJANZ (Drug) $174.47
- CIMZIA (Drug) $121.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Middletown
Jared Marshall
Medical — Payments: $6,143
Medical $6,143
Dennise Ramirez, Pa-C, PA-C
Medical — Payments: $2,095
Medical $2,095
Rebbecca Shea, Pa-C, PA-C
Medical — Payments: $1,929
Medical $1,929
Abigail Finkenauer, Pa-C, PA-C
Medical — Payments: $1,453
Medical $1,453
Jignesh Patel, Pa, PA
Medical — Payments: $897.20
Medical $897.20
Marissa Mutzek, Pa-C, PA-C
Medical — Payments: $709.10
Medical $709.10